液体クロマトグラフィー質量分析法（LC-MS）の世界市場

液体クロマトグラフィー質量分析法（LC-MS）の世界市場は2030年までに112億米ドルに達する見込み

2024年に63億米ドルと推定される液体クロマトグラフィー質量分析法（LC-MS）の世界市場は、分析期間2024-2030年にCAGR 10.1%で成長し、2030年には112億米ドルに達すると予測されます。本レポートで分析したセグメントの1つであるトリプル四重極LC-MSは、CAGR 9.3％を記録し、分析期間終了までに62億米ドルに達すると予測されています。イオントラップLC-MSセグメントの成長率は、分析期間中CAGR 10.9%と推定されます。

米国市場は17億米ドルと推定、中国はCAGR13.6％で成長予測

米国の液体クロマトグラフィー質量分析法（LC-MS）市場は、2024年に17億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに23億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは13.6%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ7.4％と8.9％と予測されています。欧州では、ドイツがCAGR 7.9%で成長すると予測されています。

世界の液体クロマトグラフィー質量分析法（LC-MS）市場- 主要動向と促進要因のまとめ

なぜLC-MSは複雑な分析アプリケーションのゴールドスタンダードになりつつあるのか？

LC-MSとして広く知られる液体クロマトグラフィー質量分析法は、科学および産業分野の幅広い分野で最も強力で不可欠な分析技術の1つとなっています。液体クロマトグラフィーの物理的分離能力と質量分析計の質量分析能力を組み合わせることで、LC-MSは混合物内の複雑な化合物の正確な同定、定量、構造解明を可能にします。この技術は、医薬品開発、バイオマーカー探索、臨床診断、プロテオミクス、メタボロミクス、環境検査において中心的な役割を果たしています。高感度でハイスループットな分析法に対する要求の高まりは、従来の技術では同レベルの分離能や精度で達成できないタスクにLC-MSシステムを採用するラボを後押ししています。製薬業界では、LC-MSは微量レベルの不純物や代謝物を検出できることから、創薬、薬物動態、品質管理に多用されています。臨床検査室では、治療薬のモニタリング、慢性疾患や感染症のバイオマーカーの検出にLC-MSが利用されています。食品安全や環境検査機関は、汚染物質、残留物、毒素を高感度で検出するためにLC-MSを使用しています。学術研究も、特にシステム生物学と個別化医療の分野で、この技術の恩恵を受けています。LC-MSの多用途性と信頼性は、イオン化技術やソフトウェア統合における絶え間ない技術革新と相まって、様々な分野にわたる精密な分子分析法としての役割を確固たるものにしています。

技術の進歩はLC-MSシステムの能力をどのように拡張していますか？

ハードウェアとソフトウェアの両方における技術の進歩は、LC-MSシステムの機能、効率、およびユーザーアクセシビリティを劇的に向上させています。飛行時間型（TOF）、オービトラップ、四重極技術などの高分解能質量分析計の開発により、分析対象物の検出と特性解析において、これまでにない精度と感度が研究者にもたらされています。これらの改良により、複雑な同重体化合物の分離、翻訳後修飾の同定、極端に存在量の低い化合物を含むサンプルの分析が可能になりました。同時に、超高性能液体クロマトグラフィー（UHPLC）機能を備えた強化されたクロマトグラフィーシステムは、よりシャープなピークと高いスループットでより速い分離を可能にしました。サンプル調製の自動化とロボットの統合は、研究室と商業研究室の両方で、人的ミスを減らし、ワークフローをスピードアップしています。ソフトウェア面では、ユーザーフレンドリーなインターフェース、クラウド接続、AIを搭載したデータ処理ツールにより、リアルタイム分析、予測モデリング、より直感的なデータの可視化が可能になっています。これらの進歩はLC-MSの民主化に貢献し、熟練した科学者が要求する強固な分析基準を維持しながら、専門家でなくてもLC-MSをより利用しやすくしています。さらに、環境モニタリング、法医学的調査、現場での医薬品品質検査などの現場ベースのアプリケーションのために、小型化されたポータブルLC-MS装置が開発されています。エレクトロスプレーイオン化（ESI）やマトリックス支援レーザー脱離イオン化（MALDI）のようなイオン源設計の革新は、効果的に分析できる分子の範囲を広げています。このような技術的向上により、LC-MSの導入が促進され、以前は実用的でなかった、あるいはコスト的に困難であった新しいアプリケーションの開発が可能になっています。

LC-MSの採用を形成している業界動向と分野特有の要求とは？

業界全体におけるLC-MSの普及は、規制要件の変化、研究ニーズの進化、分析対象の複雑化によって推進されています。製薬分野では、生物製剤、バイオシミラー、低分子化合物のより迅速で精密な特性解析への要求が、医薬品開発パイプラインの各段階へのLC-MSの統合を促しています。規制機関は、詳細な不純物プロファイリングと構造解明をますます要求しており、LC-MSはコンプライアンスと承認のための重要なツールとなっています。臨床診断の分野では、個別化医療により、特異性の高いバイオマーカー検出と薬理ゲノム・プロファイリングの需要が高まっており、これらはいずれもLC-MSプラットフォームの感度と選択性に依存しています。飲食品業界もまた、残留農薬、マイコトキシン、食品添加物のリアルタイム検査にLC-MSを利用し、消費者の安全性と規制との整合性を確保しています。環境モニタリング機関は、大気、水、土壌の汚染物質を正確に評価するためにLC-MSを利用し、汚染と生態系の健康に対する世界の懸念に対応しています。学術機関や研究機関は、ゲノミクス、メタボロミクス、疾病病理学の学際的研究をサポートするためにLC-MSの能力を拡大しています。さらに、法医学では、分析精度が最も重要な毒物学、薬物検査、犯罪捜査のためにLC-MSが採用されています。これらの分野特有の動向は、独自の使用事例に合わせた特殊なLC-MSキットやプロトコルの開発によって支えられており、市場浸透をさらに促進しています。科学界が分子探索と診断の限界に挑み続ける中、LC-MSは革新とコンプライアンスを実現する重要な手段として、成長する様々な分野で際立っています。

世界のLC-MS市場の成長加速の主な要因は？

液体クロマトグラフィー質量分析市場の成長は、分析要件の複雑化と科学的・規制的課題の拡大を反映するいくつかの相互関連的な要因によって牽引されています。最も大きな促進要因の1つは、医薬品におけるアプリケーション基盤の拡大であり、そこではLC-MSが研究開発と品質保証の両方の活動に不可欠です。より効率的で個別化されたヘルスケアの推進は、臨床診断における需要にも拍車をかけており、検査室は疾患検出、治療モニタリング、バイオマーカー検証のためのより正確なツールを求めています。ライフサイエンス研究、特にゲノミクス、プロテオミクス、メタボロミクスへの資金援助の増加は、LC-MSのような高分解能分析プラットフォームへの持続的な需要を生み出しています。世界中の規制機関は、食品安全、環境コンプライアンス、医薬品製造などの分野で基準を厳しくしており、LC-MSはこれらの要件を満たすために不可欠となっています。新興国では、ヘルスケア・インフラ、学術研究、工業品質管理への投資が、LC-MSプロバイダーに新たな市場機会をもたらしています。使いやすさを改善し、運用コストを削減し、スループットを向上させる技術の進歩も、小規模ラボや分散型検査施設にとってLC-MSをより魅力的なものにしています。さらに、LC-MSシステムと検査室情報管理システム（LIMS）および自動化プラットフォームの統合は、ワークフローの効率を高め、より広範な採用を可能にしています。装置メーカー、ソフトウェア開発者、エンドユーザー間の戦略的コラボレーションにより、特定の業界ニーズに対応したソリューションの開発が加速しています。最後に、医薬品開発業務受託機関（CRO）や第三者検査機関の台頭により、多様な分析課題に対応できる汎用性の高い高性能LC-MS装置に対する需要が高まっています。これらすべての力が、世界のLC-MS市場の力強く持続的な上昇軌道に寄与しています。

セグメント

タイプ（トリプル四重極LC-MS、イオントラップLC-MS、シングル四重極LC-MS）、エンドユース（製薬・バイオ企業エンドユース、病院・研究所エンドユース、学術・研究機関エンドユース）

調査対象企業の例

• Agilent Technologies
• Analytik Jena GmbH
• Bio-Rad Laboratories, Inc.
• Bruker Corporation
• Cleaver Scientific Ltd
• Danaher Corporation
• FOSS Analytical
• Hitachi High-Tech Corporation
• JEOL Ltd.
• LECO Corporation
• Merck KGaA
• PerkinElmer Inc.
• Restek Corporation
• SCIEX
• Shimadzu Corporation
• Skyray Instrument Co., Ltd.
• Thermo Fisher Scientific Inc.
• VWR International（Avantor）
• Waters Corporation
• Wyatt Technology Corporation

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、一般的なLLMや業界別SLMのクエリに従う代わりに、ビデオ記録、ブログ、検索エンジン調査、大量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Liquid Chromatography-Mass Spectroscopy (LC-MS) Market to Reach US$11.2 Billion by 2030

The global market for Liquid Chromatography-Mass Spectroscopy (LC-MS) estimated at US$6.3 Billion in the year 2024, is expected to reach US$11.2 Billion by 2030, growing at a CAGR of 10.1% over the analysis period 2024-2030. Triple Quadrupole LC-MS, one of the segments analyzed in the report, is expected to record a 9.3% CAGR and reach US$6.2 Billion by the end of the analysis period. Growth in the Ion trap LC-MS segment is estimated at 10.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.7 Billion While China is Forecast to Grow at 13.6% CAGR

The Liquid Chromatography-Mass Spectroscopy (LC-MS) market in the U.S. is estimated at US$1.7 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$2.3 Billion by the year 2030 trailing a CAGR of 13.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.4% and 8.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 7.9% CAGR.

Global Liquid Chromatography-Mass Spectroscopy (LC-MS) Market - Key Trends & Drivers Summarized

Why Is LC-MS Emerging as the Gold Standard in Complex Analytical Applications?

Liquid Chromatography-Mass Spectroscopy, widely known as LC-MS, has become one of the most powerful and indispensable analytical techniques across a broad range of scientific and industrial fields. By combining the physical separation capabilities of liquid chromatography with the mass analysis capabilities of mass spectrometry, LC-MS enables precise identification, quantification, and structural elucidation of complex compounds within mixtures. This technology plays a central role in pharmaceutical development, biomarker discovery, clinical diagnostics, proteomics, metabolomics, and environmental testing. The growing demand for sensitive and high-throughput analytical methods is pushing laboratories to adopt LC-MS systems for tasks that traditional techniques cannot accomplish with the same level of resolution or accuracy. In the pharmaceutical industry, LC-MS is heavily used for drug discovery, pharmacokinetics, and quality control due to its ability to detect trace levels of impurities and metabolites. Clinical laboratories rely on LC-MS for monitoring therapeutic drugs and detecting biomarkers for chronic and infectious diseases. Food safety and environmental testing agencies use LC-MS to detect contaminants, residues, and toxins with high sensitivity. Academic research is also benefiting from the technology, particularly in the fields of systems biology and personalized medicine. The versatility and reliability of LC-MS, coupled with continuous innovations in ionization techniques and software integration, are solidifying its role as the go-to method for precise molecular analysis across multiple disciplines.

How Are Technological Advancements Expanding the Capabilities of LC-MS Systems?

Technological progress in both hardware and software is dramatically enhancing the capabilities, efficiency, and user accessibility of LC-MS systems. Developments in high-resolution mass analyzers, such as time-of-flight (TOF), orbitrap, and quadrupole technologies, are providing researchers with unprecedented accuracy and sensitivity in detecting and characterizing analytes. These improvements have made it possible to resolve complex isobaric compounds, identify post-translational modifications, and analyze samples with extremely low abundance compounds. Simultaneously, enhanced chromatographic systems with ultra-high performance liquid chromatography (UHPLC) capabilities allow for faster separations with sharper peaks and higher throughput. Automation in sample preparation and robotic integration is reducing human error and speeding up workflows in both research and commercial laboratories. On the software front, user-friendly interfaces, cloud connectivity, and AI-powered data processing tools are enabling real-time analysis, predictive modeling, and more intuitive data visualization. These advancements are helping to democratize LC-MS, making it more accessible to non-experts while maintaining the robust analytical standards demanded by seasoned scientists. Additionally, miniaturized and portable LC-MS instruments are being developed for field-based applications, such as environmental monitoring, forensic investigations, and on-site pharmaceutical quality testing. Innovations in ion source design, such as electrospray ionization (ESI) and matrix-assisted laser desorption ionization (MALDI), are expanding the scope of molecules that can be effectively analyzed. Together, these technological improvements are driving greater adoption of LC-MS and enabling new applications that were previously impractical or cost-prohibitive.

What Industry Trends and Sector-Specific Demands Are Shaping LC-MS Adoption?

The widespread adoption of LC-MS across industries is being driven by changing regulatory requirements, evolving research needs, and the rising complexity of analytical targets. In the pharmaceutical sector, the demand for faster and more precise characterization of biologics, biosimilars, and small molecules is prompting companies to integrate LC-MS into every stage of the drug development pipeline. Regulatory bodies are increasingly mandating detailed impurity profiling and structural elucidation, making LC-MS a critical tool for compliance and approval. In the clinical diagnostics arena, personalized medicine is generating demand for highly specific biomarker detection and pharmacogenomic profiling, both of which rely on the sensitivity and selectivity of LC-MS platforms. The food and beverage industry is also turning to LC-MS for real-time testing of pesticide residues, mycotoxins, and food additives, ensuring consumer safety and regulatory alignment. Environmental monitoring agencies are utilizing LC-MS to assess air, water, and soil contaminants with precision, responding to global concerns over pollution and ecological health. Academic institutions and research organizations are expanding their LC-MS capabilities to support interdisciplinary studies in genomics, metabolomics, and disease pathology. Additionally, the forensic sciences have adopted LC-MS for toxicology, drug testing, and criminal investigations where analytical precision is paramount. These sector-specific trends are supported by the development of specialized LC-MS kits and protocols tailored to unique use cases, further driving market penetration. As the scientific community continues to push the boundaries of molecular discovery and diagnostics, LC-MS stands out as a critical enabler of innovation and compliance across a growing range of sectors.

What Key Factors Are Driving the Accelerated Growth of the LC-MS Market Worldwide?

The growth in the liquid chromatography-mass spectroscopy market is driven by several interconnected factors that reflect the rising complexity of analytical requirements and the broadening scope of scientific and regulatory challenges. One of the most significant drivers is the expanding application base in pharmaceuticals, where LC-MS is essential for both R&D and quality assurance activities. The push for more efficient and personalized healthcare is also fueling demand in clinical diagnostics, as laboratories seek more accurate tools for disease detection, therapeutic monitoring, and biomarker validation. Increased funding for life sciences research, particularly in genomics, proteomics, and metabolomics, is creating a sustained demand for high-resolution analytical platforms like LC-MS. Regulatory bodies across the globe are tightening standards in areas such as food safety, environmental compliance, and drug manufacturing, making LC-MS indispensable for meeting these requirements. In emerging economies, investments in healthcare infrastructure, academic research, and industrial quality control are creating new market opportunities for LC-MS providers. Technological advancements that improve ease of use, reduce operational costs, and increase throughput are also making LC-MS more attractive to smaller laboratories and decentralized testing facilities. Additionally, the integration of LC-MS systems with laboratory information management systems (LIMS) and automation platforms is enhancing workflow efficiency and enabling broader adoption. Strategic collaborations between instrument manufacturers, software developers, and end-users are accelerating the development of tailored solutions that meet specific industry needs. Finally, the rise of contract research organizations (CROs) and third-party testing labs is boosting demand for versatile, high-performance LC-MS instruments capable of handling a wide variety of analytical challenges. All of these forces are contributing to a strong and sustained upward trajectory in the global LC-MS market.

SCOPE OF STUDY:

The report analyzes the Liquid Chromatography-Mass Spectroscopy (LC-MS) market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Triple Quadrupole LC-MS, Ion trap LC-MS, Single Quadrupole LC-MS); End-Use (Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use, Academic & Research Institutes End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 36 Featured) -

• Agilent Technologies
• Analytik Jena GmbH
• Bio-Rad Laboratories, Inc.
• Bruker Corporation
• Cleaver Scientific Ltd
• Danaher Corporation
• FOSS Analytical
• Hitachi High-Tech Corporation
• JEOL Ltd.
• LECO Corporation
• Merck KGaA
• PerkinElmer Inc.
• Restek Corporation
• SCIEX
• Shimadzu Corporation
• Skyray Instrument Co., Ltd.
• Thermo Fisher Scientific Inc.
• VWR International (Avantor)
• Waters Corporation
• Wyatt Technology Corporation

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Tariff Impact on Global Supply Chain Patterns
  • Liquid Chromatography-Mass Spectroscopy (LC-MS) - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Demand for High-Throughput and High-Precision Analytical Techniques Throws the Spotlight on LC-MS Systems
  • Growth in Proteomics, Metabolomics, and Biomarker Discovery Propels Widespread Adoption of LC-MS in Life Sciences
  • Expanding Role of LC-MS in Clinical Diagnostics Strengthens Business Case for Integrated and Automated Systems
  • Advancements in High-Resolution and Triple Quadrupole Technologies Improve Sensitivity and Selectivity in Complex Analyses
  • Widespread Use in Pharmaceutical QA/QC and Drug Development Accelerates Investment in Robust LC-MS Platforms
  • Integration of LC-MS in Environmental and Food Safety Testing Spurs Adoption Across Government and Industrial Labs
  • Automation and Miniaturization Trends Enhance Throughput and Reduce Operational Complexity in LC-MS Workflows
  • Rising Incidence of Chronic and Infectious Diseases Fuels Use of LC-MS in Therapeutic Drug Monitoring and Pathogen Detection
  • Omics-Based Research and Personalized Medicine Initiatives Throw the Spotlight on Multi-Omic LC-MS Applications
  • Cloud-Enabled Data Analysis and AI Integration Improve Interpretation and Workflow Efficiency for LC-MS Operators
  • Global Expansion of Research Infrastructure and Academic Funding Supports Increased LC-MS Utilization
  • Growth of Biologics and Biosimilars Markets Drives Need for LC-MS in Structural and Impurity Characterization
  • Point-of-Care and Portable LC-MS Innovations Expand Opportunities Beyond Centralized Laboratory Settings
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Liquid Chromatography-Mass Spectroscopy (LC-MS) Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Triple Quadrupole LC-MS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Triple Quadrupole LC-MS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Triple Quadrupole LC-MS by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Ion trap LC-MS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Ion trap LC-MS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Ion trap LC-MS by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Single Quadrupole LC-MS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Single Quadrupole LC-MS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Single Quadrupole LC-MS by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Pharma & Biotech Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Pharma & Biotech Companies End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Hospitals & Research Laboratories End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Hospitals & Research Laboratories End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Hospitals & Research Laboratories End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Academic & Research Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Academic & Research Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Academic & Research Institutes End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Liquid Chromatography-Mass Spectroscopy (LC-MS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 23: USA Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 24: USA Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 25: USA 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Percentage Breakdown of Value Sales for Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS for the Years 2015, 2025 & 2030
  • TABLE 26: USA Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 27: USA Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 28: USA 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 29: Canada Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 30: Canada Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 31: Canada 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Percentage Breakdown of Value Sales for Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS for the Years 2015, 2025 & 2030
  • TABLE 32: Canada Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 33: Canada Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 34: Canada 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2015, 2025 & 2030
• JAPAN
  • Liquid Chromatography-Mass Spectroscopy (LC-MS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 35: Japan Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 36: Japan Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 37: Japan 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Percentage Breakdown of Value Sales for Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS for the Years 2015, 2025 & 2030
  • TABLE 38: Japan Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 39: Japan Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 40: Japan 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2015, 2025 & 2030
• CHINA
  • Liquid Chromatography-Mass Spectroscopy (LC-MS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 41: China Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 42: China Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 43: China 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Percentage Breakdown of Value Sales for Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS for the Years 2015, 2025 & 2030
  • TABLE 44: China Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 45: China Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 46: China 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2015, 2025 & 2030
• EUROPE
  • Liquid Chromatography-Mass Spectroscopy (LC-MS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 47: Europe Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 48: Europe Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 49: Europe 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 50: Europe Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Europe Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 52: Europe 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Percentage Breakdown of Value Sales for Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS for the Years 2015, 2025 & 2030
  • TABLE 53: Europe Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Europe Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 55: Europe 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2015, 2025 & 2030
• FRANCE
  • Liquid Chromatography-Mass Spectroscopy (LC-MS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 56: France Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: France Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 58: France 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Percentage Breakdown of Value Sales for Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS for the Years 2015, 2025 & 2030
  • TABLE 59: France Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: France Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 61: France 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2015, 2025 & 2030
• GERMANY
  • Liquid Chromatography-Mass Spectroscopy (LC-MS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 62: Germany Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Germany Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 64: Germany 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Percentage Breakdown of Value Sales for Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS for the Years 2015, 2025 & 2030
  • TABLE 65: Germany Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Germany Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 67: Germany 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 68: Italy Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Italy Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 70: Italy 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Percentage Breakdown of Value Sales for Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS for the Years 2015, 2025 & 2030
  • TABLE 71: Italy Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Italy Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 73: Italy 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Liquid Chromatography-Mass Spectroscopy (LC-MS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 74: UK Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: UK Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 76: UK 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Percentage Breakdown of Value Sales for Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS for the Years 2015, 2025 & 2030
  • TABLE 77: UK Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: UK Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 79: UK 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 80: Spain Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: Spain Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 82: Spain 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Percentage Breakdown of Value Sales for Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS for the Years 2015, 2025 & 2030
  • TABLE 83: Spain Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Spain Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 85: Spain 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 86: Russia Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Russia Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 88: Russia 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Percentage Breakdown of Value Sales for Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS for the Years 2015, 2025 & 2030
  • TABLE 89: Russia Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Russia Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 91: Russia 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Rest of Europe Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 94: Rest of Europe 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Percentage Breakdown of Value Sales for Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS for the Years 2015, 2025 & 2030
  • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Rest of Europe Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 97: Rest of Europe 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Liquid Chromatography-Mass Spectroscopy (LC-MS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 99: Asia-Pacific Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 100: Asia-Pacific 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Asia-Pacific Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 103: Asia-Pacific 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Percentage Breakdown of Value Sales for Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS for the Years 2015, 2025 & 2030
  • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Asia-Pacific Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 106: Asia-Pacific 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Liquid Chromatography-Mass Spectroscopy (LC-MS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 107: Australia Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Australia Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 109: Australia 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Percentage Breakdown of Value Sales for Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS for the Years 2015, 2025 & 2030
  • TABLE 110: Australia Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Australia Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 112: Australia 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2015, 2025 & 2030
• INDIA
  • Liquid Chromatography-Mass Spectroscopy (LC-MS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 113: India Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: India Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 115: India 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Percentage Breakdown of Value Sales for Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS for the Years 2015, 2025 & 2030
  • TABLE 116: India Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: India Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 118: India 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 119: South Korea Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: South Korea Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 121: South Korea 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Percentage Breakdown of Value Sales for Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS for the Years 2015, 2025 & 2030
  • TABLE 122: South Korea Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: South Korea Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 124: South Korea 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Rest of Asia-Pacific Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 127: Rest of Asia-Pacific 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Percentage Breakdown of Value Sales for Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS for the Years 2015, 2025 & 2030
  • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Rest of Asia-Pacific Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 130: Rest of Asia-Pacific 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Liquid Chromatography-Mass Spectroscopy (LC-MS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 131: Latin America Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 132: Latin America Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 133: Latin America 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 134: Latin America Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Latin America Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 136: Latin America 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Percentage Breakdown of Value Sales for Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS for the Years 2015, 2025 & 2030
  • TABLE 137: Latin America Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Latin America Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 139: Latin America 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 140: Argentina Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Argentina Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 142: Argentina 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Percentage Breakdown of Value Sales for Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS for the Years 2015, 2025 & 2030
  • TABLE 143: Argentina Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Argentina Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 145: Argentina 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 146: Brazil Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Brazil Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 148: Brazil 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Percentage Breakdown of Value Sales for Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS for the Years 2015, 2025 & 2030
  • TABLE 149: Brazil Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Brazil Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 151: Brazil 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 152: Mexico Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Mexico Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 154: Mexico 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Percentage Breakdown of Value Sales for Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS for the Years 2015, 2025 & 2030
  • TABLE 155: Mexico Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Mexico Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 157: Mexico 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Rest of Latin America Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 160: Rest of Latin America 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Percentage Breakdown of Value Sales for Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS for the Years 2015, 2025 & 2030
  • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Rest of Latin America Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 163: Rest of Latin America 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Liquid Chromatography-Mass Spectroscopy (LC-MS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 164: Middle East Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 165: Middle East Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 166: Middle East 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 167: Middle East Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Middle East Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 169: Middle East 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Percentage Breakdown of Value Sales for Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS for the Years 2015, 2025 & 2030
  • TABLE 170: Middle East Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Middle East Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 172: Middle East 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 173: Iran Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: Iran Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 175: Iran 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Percentage Breakdown of Value Sales for Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS for the Years 2015, 2025 & 2030
  • TABLE 176: Iran Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: Iran Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 178: Iran 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 179: Israel Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: Israel Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 181: Israel 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Percentage Breakdown of Value Sales for Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS for the Years 2015, 2025 & 2030
  • TABLE 182: Israel Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Israel Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 184: Israel 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Saudi Arabia Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 187: Saudi Arabia 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Percentage Breakdown of Value Sales for Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS for the Years 2015, 2025 & 2030
  • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Saudi Arabia Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 190: Saudi Arabia 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 191: UAE Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: UAE Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 193: UAE 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Percentage Breakdown of Value Sales for Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS for the Years 2015, 2025 & 2030
  • TABLE 194: UAE Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: UAE Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 196: UAE 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Rest of Middle East Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 199: Rest of Middle East 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Percentage Breakdown of Value Sales for Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS for the Years 2015, 2025 & 2030
  • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Rest of Middle East Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 202: Rest of Middle East 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2015, 2025 & 2030
• AFRICA
  • Liquid Chromatography-Mass Spectroscopy (LC-MS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 203: Africa Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Africa Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 205: Africa 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Percentage Breakdown of Value Sales for Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS for the Years 2015, 2025 & 2030
  • TABLE 206: Africa Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Africa Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 208: Africa 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2015, 2025 & 2030

IV. COMPETITION